Growth restriction in the rat alters expression of cardiac JAK/STAT genes in a sex-specific manner

Journal of Developmental Origins of Health and Disease

Volumn 5, Issue 4, 2014, Pages 314-321

  Van Der Linde, S ^a   Romano, T ^b   Wadley, G ^c   Jeffries, A J ^a   Wlodek, M E ^a   Hryciw, D H ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

Author keywords

born small; genes; JAK STAT

Indexed keywords

JAK2 PROTEIN, RAT; JANUS KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; SOCS3 PROTEIN, RAT; STAT3 PROTEIN; STAT3 PROTEIN, RAT; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING;

AGE; ANALYSIS OF VARIANCE; ANIMAL; CARDIOVASCULAR DISEASES; FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA INSUFFICIENCY; PREGNANCY; RAT; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SEXUAL DEVELOPMENT; SIGNAL TRANSDUCTION; WISTAR RAT;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; CARDIOVASCULAR DISEASES; FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION REGULATION; JANUS KINASE 2; MALE; MYOCARDIUM; PHOSPHATIDYLINOSITOL 3-KINASES; PLACENTAL INSUFFICIENCY; PREGNANCY; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84903275921     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174414000245     Document Type: Article

References (43)

1. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ. 1989; 298, 564-567.
2. Eriksson J, Forsen T, Tuomilehto J, Osmond C, Barker D. Fetal and childhood growth and hypertension in adult life. Hypertension. 2000; 36, 790-794.
3. Wlodek ME, Westcott K, Siebel AL, Owens JA, Moritz KM. Growth restriction before or after birth reduces nephron number and increases blood pressure in male rats. Kidney Int. 2008; 74, 187-195.
4. O'Dowd R, Kent JC, Moseley JM, Wlodek ME. Effects of uteroplacental insufficiency and reducing litter size on maternal mammary function and postnatal offspring growth. Am J Physiol Regul Integr Comp Physiol. 2008; 294, R539-R548.
5. Wlodek ME, Mibus A, Tan A, et al. Normal lactational environment restores nephron endowment and prevents hypertension after placental restriction in the rat. J Am Soc Nephrol. 2007; 18, 1688-1696.
6. Black MJ, Siebel AL, Gezmish O, Moritz KM, Wlodek ME. Normal lactational environment restores cardiomyocyte number after uteroplacental insufficiency: implications for the preterm neonate. Am J Physiol Regul Integr Comp Physiol. 2012; 302, R1101-R1110.
7. Wadley GD, McConell GK, Goodman CA, et al. Growth restriction in the rat alters expression of metabolic genes during postnatal cardiac development in a sex-specific manner. Physiol Genomics. 2013; 45, 99-105.
8. Wadley GD, Wlodek ME, Ng G, et al. Growth restriction before and after birth increases kinase signaling pathways in the adult rat heart. J Dev Orig Health Dis. 2010; 1, 376-385.
9. Rudolph A. Myocardial growth before and after birth: clinical implications. Acta Paediatr. 2000; 89, 129-133.
10. Li F, Wang X, Capasso JM, Gerdes AM. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol. 1996; 28, 1737-1746.
11. Xue Q, Dasgupta C, Chen M, Zhang L. Foetal hypoxia increases cardiac AT(2)R expression and subsequent vulnerability to adult ischaemic injury. Cardiovasc Res. 2011; 89, 300-308.
12. Louey S, Jonker SS, Giraud GD, Thornburg KL. Placental insufficiency decreases cell cycle activity and terminal maturation in fetal sheep cardiomyocytes. J Physiol. 2007; 580, 639-648.
13. Bubb KJ, Cock ML, Black MJ, et al. Intrauterine growth restriction delays cardiomyocyte maturation and alters coronary artery function in the fetal sheep. J Physiol. 2007; 578, 871-881.
14. Corstius HB, Zimanyi MA, Maka N, et al. Effect of intrauterine growth restriction on the number of cardiomyocytes in rat hearts. Pediatr Res. 2005; 57, 796-800.
15. Lim K, Zimanyi MA, Black MJ. Effect of maternal protein restriction during pregnancy and lactation on the number of cardiomyocytes in the postproliferative weanling rat heart. Anat Rec. 2010; 293, 431-437.
16. Barouch LA, Berkowitz DE, Harrison RW, O'Donnell CP, Hare JM. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation. 2003; 108, 754-759.
17. Clerk A, Sugden PH. Inflame my heart (by p38-MAPK). Circ Res. 2006; 99, 455-458.
18. Shiojima I, Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev. 2006; 20, 3347-3365.
19. Giani JF, Gironacci MM, Munoz MC, et al. Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors. Am J Physiol Heart Circ Physiol. 2007; 293, H1154-H1163.
20. Trivedi P, Yang R, Barouch LA. Decreased p110alpha catalytic activity accompanies increased myocyte apoptosis and cardiac hypertrophy in leptin deficient ob/ob mice. Cell Cycle. 2008; 7, 560-565.
21. Yasukawa H, Nagata T, Oba T, Imaizumi T. SOCS3: a novel therapeutic target for cardioprotection. JAKSTAT. 2012; 1, 234-240.
22. Wlodek ME, Westcott KT, O'Dowd R, et al. Uteroplacental restriction in the rat impairs fetal growth in association with alterations in placental growth factors including PTHrP. Am J Physiol Regul Integr Comp Physiol. 2005; 288, R1620-R1627.
23. Wadley GD, Siebel AL, Cooney GJ, et al. Uteroplacental insufficiency and reducing litter size alters skeletal muscle mitochondrial biogenesis in a sex-specific manner in the adult rat. Am J Physiol Endocrinol Metab. 2008; 294, E861-E869.
24. Wadley GD, McConell GK. High-dose antioxidant vitamin C supplementation does not prevent acute exercise-induced increases in markers of skeletal muscle mitochondrial biogenesis in rats. J Appl Physiol. 2010; 108, 1719-1726.
25. Sun SL, Li TJ, Yang PY, Qiu Y, Rui YC. Modulation of signal transducers and activators of transcription (STAT) factor pathways during focal cerebral ischaemia: a gene expression array. Clin Exp Pharmacol Physiol. 2007; 34, 1097-1101.
26. Song L, Li Y, Sun YX, Yu M, Shen BF. IL-6 inhibits apoptosis of human myeloma cell line XG-7 through activation of JAK/STAT pathway and up-regulation of Mcl-1. Ai Zheng. 2002; 21, 113-116.
27. Parganas E, Wang D, Stravopodis D, et al. Jak2 is essential for signaling through a variety of cytokine receptors. Cell. 1998; 93, 385-395.
28. Foshay K, Rodriguez G, Hoel B, Narayan J, Gallicano GI. JAK2/STAT3 directs cardiomyogenesis within murine embryonic stem cells in vitro. Stem Cells. 2005; 23, 530-543.
29. Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G. The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther. 2008; 120, 172-185.
30. Hilfiker-Kleiner D, Hilfiker A, Drexler H. Many good reasons to have STAT3 in the heart. Pharmacol Ther. 2005; 107, 131-137.
31. Hamilton KL, Lin L, Wang Y, Knowlton AA. Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression. Physiol Genomics. 2008; 32, 254-263.
32. Knowlton AA, Lee AR. Estrogen and the cardiovascular system. Pharmacol Ther. 2012; 135, 54-70.
33. Smith JT, Waddell BJ. Developmental changes in plasma leptin and hypothalamic leptin receptor expression in the rat: peripubertal changes and the emergence of sex differences. J Endocrinol. 2003; 176, 313-319.
34. Eisenreich A, Rauch U. PI3K inhibitors in cardiovascular disease. Cardiovasc Ther. 2010; 29, 29-36.
35. Clifton VL. Review: sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta. 2010; 24, S33-S39.
36. Kodama H, Fukuda K, Pan J, et al. Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res. 1997; 81, 656-663.
37. Huang Y, Du M, Zhuang S, Shen Z, Li Y. Impaired growth hormone receptor signaling during non-catch-up growth in rats born small for gestational age. Horm Res Paediatr. 2010; 74, 106-113.
38. de Zegher F, Maes M, Gargosky SE, et al. High-dose growth hormone treatment of short children born small for gestational age. J Clin Endocrinol Metab. 1996; 81, 1887-1892.
39. Woodall SM, Bassett NS, Gluckman PD, Breier BH. Consequences of maternal undernutrition for fetal and postnatal hepatic insulin-like growth factor-I, growth hormone receptor and growth hormone binding protein gene regulation in the rat. J Mol Endocrinol. 1998; 20, 313-326.
40. Thirone ACP, Carvalho CRO, Saad MJA. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and shc in rat tissues. Endocrinology. 1999; 140, 55-62.
41. Saccà L, Cittadini A, Fazio S. Growth hormone and the heart. Endocrine Rev. 1994; 15, 555-573.
42. Brüela A, Christoffersen TEH, Nyengaard JR. Growth hormone increases the proliferation of existing cardiac myocytes and the total number of cardiac myocytes in the rat heart. Cardiovasc Res. 2007; 76, 400-408.
43. Lewandowski AJ, Augustine D, Lamata P, et al. Preterm heart in adult life: cardiovascular magnetic resonance reveals distinct differences in left ventricular mass, geometry, and function. Circulation. 2013; 127, 197-206.